Your browser doesn't support javascript.
loading
A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease.
Dagorn, Pascale Gluais; Buchholz, Bjoern; Kraus, Andre; Batchuluun, Battsetseg; Bange, Hester; Blockken, Laura; Steinberg, Gregory R; Moller, David E; Hallakou-Bozec, Sophie.
Afiliação
  • Dagorn PG; Poxel SA, Lyon, France.
  • Buchholz B; Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Kraus A; Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Batchuluun B; Centre for Metabolism, Obesity and Diabetes Research, Department of Medicine and Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.
  • Bange H; Crown Bioscience Netherlands B.V., The Netherlands.
  • Blockken L; InnoSer België NV, Belgium.
  • Steinberg GR; Centre for Metabolism, Obesity and Diabetes Research, Department of Medicine and Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.
  • Moller DE; Poxel SA, Lyon, France.
  • Hallakou-Bozec S; Poxel SA, Lyon, France. Electronic address: sophie.bozec@poxelpharma.com.
Kidney Int ; 103(5): 917-929, 2023 05.
Article em En | MEDLINE | ID: mdl-36804411

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rim Policístico Autossômico Dominante / Cistos / Insuficiência Renal Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rim Policístico Autossômico Dominante / Cistos / Insuficiência Renal Idioma: En Ano de publicação: 2023 Tipo de documento: Article